VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $427,000 | -40.8% | 29,382 | 0.0% | 0.13% | -16.8% |
| Q3 2016 | $721,000 | +21.8% | 29,382 | 0.0% | 0.16% | +10.3% |
| Q2 2016 | $592,000 | -23.4% | 29,382 | 0.0% | 0.15% | -32.4% |
| Q1 2016 | $773,000 | -74.1% | 29,382 | 0.0% | 0.22% | -71.4% |
| Q4 2015 | $2,987,000 | -19.2% | 29,382 | +41.9% | 0.76% | +4.7% |
| Q3 2015 | $3,695,000 | -5.9% | 20,712 | +17.2% | 0.72% | +17.0% |
| Q2 2015 | $3,927,000 | +11.8% | 17,678 | 0.0% | 0.62% | +10.0% |
| Q1 2015 | $3,511,000 | +38.8% | 17,678 | 0.0% | 0.56% | +39.3% |
| Q4 2014 | $2,530,000 | +9.1% | 17,678 | 0.0% | 0.40% | +1.5% |
| Q3 2014 | $2,319,000 | +37.8% | 17,678 | +32.5% | 0.40% | +45.1% |
| Q2 2014 | $1,683,000 | +11.8% | 13,343 | +16.9% | 0.27% | +5.4% |
| Q1 2014 | $1,505,000 | – | 11,418 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |